Introduction
PursueCare, a leader in virtual addiction treatment, has relaunched RESET and RESET-O, two FDA-cleared prescription digital therapeutics (PDTs), designed to help individuals struggling with substance use disorder (SUD) and opioid use disorder (OUD). Originally developed by Pear Therapeutics, the two digital solutions have now been rebranded and integrated into PursueCare’s virtual addiction treatment platform. These innovative therapeutics deliver a 12-week self-guided course of cognitive behavioral therapy (CBT), incentivizing patients to complete treatment and make progress toward recovery.
RESET and RESET-O reflect PursueCare’s mission to provide accessible and personalized care, aligning with value-based care models that aim to improve treatment outcomes and patient engagement.
Overview of PursueCare’s Acquisition of RESET and RESET-O
The Transition from Pear Therapeutics to PursueCare
Initially developed by Pear Therapeutics, RESET and RESET-O were groundbreaking in their FDA approval for treating SUD and OUD. However, following Pear Therapeutics’ Chapter 11 bankruptcy filing in 2023, its assets were auctioned off, including the intellectual property for RESET and RESET-O. PursueCare acquired these assets in December 2023, following a successful $20 million Series B funding round.
The acquisition signaled a significant step in PursueCare’s strategy to deliver personalized, tech-driven addiction treatment. By integrating these PDTs into their virtual care platform, PursueCare can now offer enhanced support for patients while extending their reach to more health plans and outpatient clinics.
What Are RESET and RESET-O?
RESET is designed to treat substance use disorder (SUD), while RESET-O focuses on treating opioid use disorder (OUD). Both therapeutics offer a 12-week course of cognitive behavioral therapy (CBT), a proven method for helping patients break free from addiction. These PDTs provide patients with self-directed lessons that encourage them to stay compliant with treatment, reduce substance use, and improve their overall well-being.
The PDTs aim to complement outpatient care by offering real-time tracking of patient progress and engagement, further aligning with value-based care models that focus on outcomes rather than services.
Features of RESET and RESET-O
Self-Guided Cognitive Behavioral Therapy
RESET and RESET-O are designed to offer self-guided CBT for patients. The courses last 12 weeks, during which patients can access interactive lessons that focus on overcoming addiction and maintaining treatment adherence. The digital therapeutics offer real-time feedback, helping patients stay on track with their goals.
This self-directed nature of the PDTs empowers patients to manage their treatment at their own pace, which is critical for those who may struggle to attend regular in-person therapy sessions due to time constraints or geographical barriers.
Integration with Outpatient Care and Value-Based Models
RESET and RESET-O are not standalone products. They are designed to integrate seamlessly with outpatient care programs, allowing patients to receive ongoing support and monitor their progress throughout their recovery journey. This integration is especially important in value-based care models, where healthcare providers are rewarded for the quality and outcomes of care rather than the volume of services provided.
By offering these PDTs in collaboration with outpatient clinics, PursueCare is helping to ensure uninterrupted support for patients, whether they are being treated for SUD or OUD. Additionally, this partnership enables customized progress tracking, which is crucial for both patients and healthcare providers.
Impact on Substance Use Disorder and Opioid Use Disorder Treatment
Addressing Patient Engagement and Treatment Compliance
One of the most significant challenges in treating addiction is keeping patients engaged in their treatment programs. RESET and RESET-O directly address this issue by incentivizing patients to complete lessons and stay compliant with their treatment plans. The use of gamification techniques and behavioral incentives motivates patients to stay focused on their recovery goals.
In a field where treatment adherence is often low, the ability of these PDTs to improve engagement is a game-changer for both patients and providers. Patients are more likely to complete their treatment, leading to better outcomes and reduced relapse rates.
Supporting Value-Based Care Initiatives
In today’s healthcare landscape, value-based care is becoming the standard, particularly for chronic conditions like SUD and OUD. RESET and RESET-O are designed to align with this model by focusing on measurable outcomes, such as reduced substance use and improved patient engagement.
By delivering better outcomes, these PDTs help healthcare providers meet the goals of value-based care contracts, improving both patient health and financial performance. PursueCare is leveraging this alignment by focusing on collaborations with health plans that prioritize value-based care arrangements.
The Future of Digital Therapeutics at PursueCare
Strategic Partnerships with Clinics
PursueCare is actively forming partnerships with outpatient clinics to distribute RESET and RESET-O to more patients. This move will expand access to the PDTs, ensuring that individuals who might not have access to traditional in-person therapy can still receive high-quality care through virtual treatment options.
These partnerships are critical for scaling the use of digital therapeutics in addiction treatment, allowing more clinics to offer these tools as part of a comprehensive care package.
Expanding Access and Adoption
Looking ahead, PursueCare plans to continue expanding the availability of RESET and RESET-O across a broader network of providers. As digital therapeutics become more accepted in mainstream healthcare, PursueCare aims to remain at the forefront of this movement by offering cutting-edge tools that empower patients and improve health outcomes.
Conclusion
PursueCare’s acquisition and re-release of RESET and RESET-O represent a significant advancement in the treatment of SUD and OUD. By integrating these digital therapeutics into its virtual care platform, PursueCare is enhancing patient engagement, improving treatment adherence, and aligning with the growing trend of value-based care. As digital therapeutics continue to revolutionize healthcare, PursueCare is well-positioned to lead the way in providing accessible, high-quality addiction treatment.
Discover the latest Provider news updates with a single click. Follow DistilINFO HospitalIT and stay ahead with updates on medical advancements. Join our community today!
FAQs
Q1: What are RESET and RESET-O used for?
Ans: RESET is used for treating substance use disorder (SUD), while RESET-O is designed for opioid use disorder (OUD). Both offer cognitive behavioral therapy in a digital format.
Q2: How do RESET and RESET-O support patient engagement?
Ans: These digital therapeutics use self-guided lessons and behavioral incentives to keep patients engaged and compliant with their treatment plans.
Q3: What makes RESET and RESET-O different from traditional therapy?
Ans: RESET and RESET-O offer a virtual, self-directed 12-week cognitive behavioral therapy program, making treatment more accessible and flexible for patients.
Q4: How do RESET and RESET-O align with value-based care?
Ans: These PDTs focus on delivering measurable outcomes, such as improved patient engagement and reduced substance use, which align with value-based care models.
